BioBridgeXAll companies

Platelet BioGenesis, Inc.

Biotechnology company · Boston, Massachusetts, United States

Platelet BioGenesis, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2014. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $5.4 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2017.

www.plateletbiogenesis.comProfile compiled from public records. Is this your company? Request a correction or update

Platelet BioGenesis at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2014
Employees (self-reported, 2025)10
SEC CIK1679766

What does Platelet BioGenesis do?

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $5.4 million in total (2016 to 2025). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Eye Institute.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $10 million sold (2017).

Frequently asked questions about Platelet BioGenesis

Where is Platelet BioGenesis headquartered?

Platelet BioGenesis, Inc. is headquartered in Boston, Massachusetts, United States.

What does Platelet BioGenesis do?

Platelet BioGenesis, Inc. is a biotechnology company.

When was Platelet BioGenesis founded?

The earliest incorporation on record for Platelet BioGenesis, Inc. is in 2014, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences